Expression of recombinant human α-lactalbumin in milk of transgenic cloned pigs is sufficient to enhance intestinal growth and weight gain of suckling piglets

Gene
Jin MaNing Li

Abstract

Human α-lactalbumin (HLA) has very high nutritional value and important physiological functions during the neonatal period. The peptides derived from HLA provide diverse health benefits including antimicrobial, antiviral, immune-modulating, and antihypertensive effects. Thus, it is worth investigating the effects on offspring development of increasing HLA in milk. In this study, we found that recombinant human α-lactalbumin (rHLA) exhibits efficient inhibition of dipeptidyl peptidase-IV (DPP-IV) activity in an in vitro simulated gastrointestinal digestion system. Using a BAC clone containing the complete HLA gene as a candidate vector, we generated two lines of transgenic cloned sows via somatic cell nuclear transfer that over-expressed rHLA. The average concentrations of rHLA in milk from the two lines of transgenic cloned sows were 2.24 ± 0.71 mg/ml and 2.67 ± 1.29 mg/ml. The feeding experiments revealed that rHLA represses dipeptidyl peptidase-IV (DPP-IV) activity in vivo. Furthermore, the piglets reared by rHLA transgenic cloned sows exhibit better performance in gain of body weight and intestine growth than the control piglets reared by non-transgenic sows. Therefore, these findings indicate that rHLA could serve as a natu...Continue Reading

References

May 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·M G MurrayE Wimmer
Jul 1, 1988·The Journal of General Virology·J JoreB E Enger-Valk
Feb 1, 1968·Proceedings of the National Academy of Sciences of the United States of America·K BrewR L Hill
Jun 5, 1970·Biochemical and Biophysical Research Communications·W A Klee, C B Klee
Jul 5, 1994·Proceedings of the National Academy of Sciences of the United States of America·M G StinnakreJ C Mercier
Jul 23, 1996·Proceedings of the National Academy of Sciences of the United States of America·D J DruckerP L Brubaker
May 20, 2000·FEBS Letters·E A Permyakov, L J Berliner
Aug 18, 2000·The Journal of Clinical Endocrinology and Metabolism·B HartmannJ J Holst
Aug 2, 2003·Critical Reviews in Clinical Laboratory Sciences·Anne-Marie LambeirIngrid De Meester
May 1, 1954·American Journal of Public Health and the Nation's Health·J E SALKP L BAZELEY
Jul 13, 1957·Journal of the American Medical Association·A B SABIN
Aug 16, 2006·Journal of Animal Science·K M MarshallM B Wheeler
Nov 8, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Konstantin Chumakov, Ellie Ehrenfeld
May 7, 2010·Journal of Proteome Research·Angelo D'AlessandroLello Zolla
May 25, 2011·Expert Review of Vaccines·Pauline VerdijkWilfried A M Bakker
May 25, 2012·Vaccine·Steven B Black, Stanley A Plotkin
Mar 6, 2013·Journal of Paediatrics and Child Health·Bo Lönnerdal
Jul 11, 2013·Journal of Agricultural and Food Chemistry·Isabelle M E Lacroix, Eunice C Y Li-Chan
Jul 23, 2015·Applied Microbiology and Biotechnology·Tzi Bun NgJiang Xia
Aug 28, 2015·MMWR. Morbidity and Mortality Weekly Report·Nicoletta PrevisaniHamid S Jafari

❮ Previous
Next ❯

Citations

Oct 5, 2016·Biochemical Pharmacology·T G VillaJ M Ageitos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.